1. Home
  2. FUSE vs FEMY Comparison

FUSE vs FEMY Comparison

Compare FUSE & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUSE

Fusemachines Inc.

N/A

Current Price

$1.54

Market Cap

26.0M

Sector

Technology

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.40

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSE
FEMY
Founded
2013
2004
Country
United States
United States
Employees
270
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
23.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FUSE
FEMY
Price
$1.54
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
6.3M
344.8K
Earning Date
06-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.71
EPS
N/A
N/A
Revenue
N/A
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.77
52 Week Low
$0.80
$0.31
52 Week High
$3.67
$1.16

Technical Indicators

Market Signals
Indicator
FUSE
FEMY
Relative Strength Index (RSI) 47.57 44.74
Support Level $1.50 $0.33
Resistance Level $1.99 $0.44
Average True Range (ATR) 0.18 0.03
MACD -0.03 0.00
Stochastic Oscillator 4.08 49.85

Price Performance

Historical Comparison
FUSE
FEMY

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: